FDG-PET/CT imaging of ovarian cancer

Abstract

Ovarian cancer is the second most common gynecologic malignancy (after cervical cancer), with a lifetime risk of 1.7 %. Although its incidence has decreased slightly over the past 30 years, it is currently the most common cause of death among women with gynecologic malignancies. Imaging, especially ultrasound and CT, has become a critical part of the evaluation of patients with ovarian cancer. As for many other malignancies, the role of FDG-PET and PET/CT is being extensively studied for the evaluation of ovarian malignancy, and the goals of oncologic imaging with PET/CT are to help differentiate benign from malignant disease, to determine the extent of malignant disease, to detect residual and recurrent disease, and to monitor and guide therapy. In this chapter the PET/CT application in oncologic imaging will be reviewed.